The Russian Sputnik V vaccine against the coronavirus may be approved in 2022. This will be done after checking the information about this medicine. This was announced to TASS by Hans Kluge, the World Health Organization (WHO) Regional Director for Europe.

He added that representatives of the WTO and the Russian Direct Investment Fund met in late November to discuss the approval of Sputnik V.

The WTO requested additional information on the quality, safety, and efficacy of this vaccine.

These data are expected to be submitted by the end of December, and their verification process will be completed shortly thereafter.